S1 Protocols
Plasmid constructs. The parental vector pTRE-HBVT (1), based on plasmid pTRE2hyg (Clontech), contains a 1.05x HBV genome of genotype D (Genbank accession no.: J02203), subtype ayw (2) , in which authentic pgRNA is transcribed from the TRE promoter. All mutations in the RT domain were introduced by standard mutagenic PCR. Presence of the desired mutations was confirmed by DNA sequencing.
The specific RT domain mutations (corresponding nucleotide exchanges are given in parentheses; altered nucleotides in lower case) were rtV173L (gTG>tTG), rtL180M (cTG>aTG), and rtM204I (ATg>ATt) for LAM; rtA181T (gCT>aCT) and rtN236T (AaC>AcC) for ADV. The corresponding six HBV variants were M204I; L180M+M204V; V173L+L180M+M204V; A181T; N236T; and A181T+N236T. Amino acid numbering is based on the consensus nomenclature where the first residue of the highly conserved motif EDWGPCDEHG is assigned position 1 (3). For the vaccine escape variants, nearly the complete S gene (positions 1437-2117 in the numbering system (4) in which the A residue of the core ORF ATG marks position 1) from the Avr II site (position 1460) to the Bsr GI site (position 2050) was replaced by corresponding fragments from a genotype A isolate carrying the sG145R mutation (accession no. AF134134) and a genotype D isolate (accession no. AF134141) carrying the sY100C (TaT>TgT) plus P120T (cCT>aCT) mutations (5); both were kindly provided by W.F. Carman. For the sG145R construct, the original nucleotide sequence specifying S amino acids D144 and R145 was GAt aGA, causing a premature stop in the overlapping polymerase ORF (underlined); to rescue polymerase production, the D144 codon was changed to GAc, as present in the parental pTRE-HBVT vector; this exchange causes an R488Q (R153Q in the RT nomenclature) in the polymerase. Resequencing revealed the presence of two additional amino acid exchanges in S (GtT>GgT, sV190G; cCA>gCA sP203A) compared to the Genbank sequence; these were not further modified. In total, the S protein in the construct differs at 17 positions from that in the wild-type HBV genomes into a CMV promoter driven expression plasmid, pCWM-9/3088, homologous to the HBV vector pCH-9/3091 (6). The sequence of the best performing clone (7) differs at 7
positions from that of WMHBV-2 (A1662G; A2322G; A2564G; A2582G; T2584G; A2607G; A2622G). Plasmid pTRE-WMHBV was assembled analogously to pTRE-HBVT using conventional DNA cloning procedures.
Cell culture, transfections, and clone selection. The HepG2.TA2-7 cell line (1) contains a stably integrated gene for the tTA2 version (8) of tTA, providing for high level and strict Doxcontrolled gene expression. Cells were cultured in a fully humidified atmosphere containing 5% CO 2 , 95% air at 37 in high glucose Dulbecco's minimal essential medium (Thermo Scientific) supplemented with 10% heat-inactivated fetal bovine serum (Thermo Scientific), 1% (v/v) non-essential amino acids (Invitrogen), 2 mM L-glutamine, 100 µg/mL of streptomycin, and 100 U/mL of penicillin G, buffered with sodium bicarbonate. As a precaution against inadvertent selection of altered cell clones, cells were passaged no longer than 3 months and then were replaced by low passage cells from frozen stocks.
For transfection with the pTRE-HBV vectors, exponentially growing HepG2.TA2-7 cells were seeded in 6-well plates at 2 × 10 5 cells per well, grown for 24 h, then transfected using 
Detection of replicative HBV DNAs by Southern blotting.
Southern blotting was performed as previously described (7, 9 Native agarose gel electrophoresis (NAGE). NAGE was performed with aliquots from cytoplasmic extracts as previously described (7, 9) except the extracts were supplemented with a protease inhibitor cocktail (Roche). For semiquantitative comparisons, the aliquots were adjusted for equal total protein content, as confirmed by Western blotting against β-actin. Samples were electrophoresed through 1% agarose gels. For detection of HBV capsids, gels were blotted to a PVDF membrane, followed by incubation with the HBV core protein specific monoclonal antibody mAb 312 (10) conjugated to peroxidase. Bands were visualized using a chemiluminescent substrate (ECL+, GE Healthcare) and X-ray film.
For detection of encapsidated viral DNA, gels were blotted on a positively charged nylon 
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